Intec Pharma Ltd
(NASDAQ : NTEC)

( )
NTEC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-7.27%91.8318.6%$115.61m
AMRNAmarin Corporation Plc Sponsored ADR
1.34%17.432.0%$110.08m
SAGESAGE Therapeutics, Inc.
-1.00%146.189.5%$75.87m
JAZZJazz Pharmaceuticals Plc
-1.24%125.212.2%$72.29m
PRGOPerrigo Co. Plc
-1.29%48.316.8%$61.64m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.32%143.956.3%$58.83m
CTLTCatalent Inc
-0.54%42.562.4%$43.41m
PTLAPortola Pharmaceuticals, Inc.
0.67%30.157.7%$42.79m
ICLRICON Plc
-2.58%142.154.1%$34.10m
UTHRUnited Therapeutics Corporation
-0.74%117.0214.4%$30.49m
HZNPHorizon Pharma plc
-1.39%21.247.4%$29.47m
CORTCorcept Therapeutics Incorporated.
-2.03%11.095.5%$29.29m
MDCOMedicines Company
0.04%23.9021.8%$27.19m
AERIAerie Pharmaceuticals, Inc.
-2.30%38.706.9%$25.97m
IRWDIronwood Pharmaceuticals, Inc. Class A
-0.84%14.1810.1%$24.42m

Company Profile

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which focuses on developing drugs based on its proprietary Accordion Pill platform technology. Its product pipeline includes four product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients; Accordion Pill Zaleplon, which is being developed for the treatment of insomnia, including sleep induction and the improvement of sleep maintenance; an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug which induces ulcers; and AP-CBD/THC, an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol and tetrahydrocannabinol, which is being developed for various indications including low back neuropathic pain and fibromyalgia. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel.